Variant report

Variant	esv3335342
Chromosome Location	chr17:19436410-19438558
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr17:19437832-19438229	GM12878	blood:	n/a	n/a
2	BACH1	chr17:19436948-19436955	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr17:19437193-19437661	H1-hESC	embryonic stem cell:	n/a	n/a
4	CEBPD	chr17:19436904-19437400	HepG2	liver:	n/a	n/a
5	CEBPD	chr17:19437435-19437905	HepG2	liver:	n/a	n/a
6	CHD2	chr17:19437140-19437339	HepG2	liver:	n/a	n/a
7	CREB1	chr17:19436943-19437324	A549	lung:	n/a	n/a
8	CTCF	chr17:19437131-19437186	MCF-7	breast:	n/a	n/a
9	CTCF	chr17:19437580-19437730	SK-N-SH_RA	brain:	n/a	chr17:19437664-19437677
10	E2F6	chr17:19436875-19437865	A549	lung:	n/a	chr17:19437463-19437471 chr17:19437463-19437470 chr17:19437462-19437473 chr17:19437463-19437471 chr17:19437462-19437472 chr17:19436915-19436925
11	E2F6	chr17:19437108-19437782	H1-hESC	embryonic stem cell:	n/a	chr17:19437463-19437471 chr17:19437463-19437470 chr17:19437462-19437473 chr17:19437463-19437471 chr17:19437462-19437472
12	ELF1	chr17:19436985-19437285	HepG2	liver:	n/a	n/a
13	EP300	chr17:19437004-19437332	HepG2	liver:	n/a	n/a
14	FOXA1	chr17:19436917-19437346	HepG2	liver:	n/a	n/a
15	GABPA	chr17:19437425-19437845	H1-hESC	embryonic stem cell:	n/a	n/a
16	GABPA	chr17:19437420-19437813	H1-hESC	embryonic stem cell:	n/a	n/a
17	HA-E2F1	chr17:19436812-19437790	MCF-7	breast:	n/a	chr17:19437463-19437471 chr17:19437463-19437470 chr17:19437462-19437473 chr17:19437463-19437471 chr17:19437462-19437472 chr17:19436915-19436925
18	HDAC2	chr17:19437432-19437952	HepG2	liver:	n/a	n/a
19	HDAC2	chr17:19437057-19437935	MCF-7	breast:	n/a	n/a
20	HDAC2	chr17:19436626-19437287	HepG2	liver:	n/a	n/a
21	HEY1	chr17:19437468-19438032	HepG2	liver:	n/a	chr17:19437593-19437608
22	HEY1	chr17:19436862-19437429	HepG2	liver:	n/a	n/a
23	HEY1	chr17:19437442-19437929	HepG2	liver:	n/a	chr17:19437593-19437608
24	HEY1	chr17:19436646-19437445	HepG2	liver:	n/a	n/a
25	HNF4A	chr17:19437468-19437883	HepG2	liver:	n/a	chr17:19437700-19437714 chr17:19437701-19437713 chr17:19437701-19437714 chr17:19437700-19437713 chr17:19437698-19437716 chr17:19437701-19437714 chr17:19437701-19437713 chr17:19437844-19437858 chr17:19437701-19437714 chr17:19437699-19437714 chr17:19437701-19437713
26	HNF4A	chr17:19436839-19437871	HepG2	liver:	n/a	chr17:19437700-19437714 chr17:19437701-19437713 chr17:19437701-19437714 chr17:19437700-19437713 chr17:19437698-19437716 chr17:19437701-19437714 chr17:19437701-19437713 chr17:19437844-19437858 chr17:19437701-19437714 chr17:19437699-19437714 chr17:19437701-19437713
27	HNF4A	chr17:19436892-19437180	HepG2	liver:	n/a	n/a
28	HNF4A	chr17:19436853-19437288	HepG2	liver:	n/a	n/a
29	HNF4A	chr17:19437448-19437908	HepG2	liver:	n/a	chr17:19437700-19437714 chr17:19437701-19437713 chr17:19437701-19437714 chr17:19437700-19437713 chr17:19437698-19437716 chr17:19437701-19437714 chr17:19437701-19437713 chr17:19437844-19437858 chr17:19437701-19437714 chr17:19437699-19437714 chr17:19437701-19437713
30	HNF4G	chr17:19436778-19437240	HepG2	liver:	n/a	n/a
31	HNF4G	chr17:19437498-19437916	HepG2	liver:	n/a	chr17:19437700-19437714 chr17:19437701-19437713 chr17:19437701-19437714 chr17:19437700-19437713 chr17:19437698-19437716 chr17:19437701-19437714 chr17:19437700-19437715 chr17:19437701-19437713 chr17:19437844-19437858 chr17:19437701-19437714 chr17:19437701-19437713
32	HNF4G	chr17:19437361-19437886	HepG2	liver:	n/a	chr17:19437700-19437714 chr17:19437701-19437713 chr17:19437701-19437714 chr17:19437700-19437713 chr17:19437698-19437716 chr17:19437701-19437714 chr17:19437700-19437715 chr17:19437701-19437713 chr17:19437844-19437858 chr17:19437701-19437714 chr17:19437701-19437713
33	JUND	chr17:19436975-19437517	A549	lung:	n/a	n/a
34	MAX	chr17:19437073-19437544	ECC-1	luminal epithelium:	n/a	n/a
35	MAX	chr17:19436948-19437704	ECC-1	luminal epithelium:	n/a	n/a
36	MAX	chr17:19436638-19438058	A549	lung:	n/a	n/a
37	MAX	chr17:19437028-19437844	H1-hESC	embryonic stem cell:	n/a	n/a
38	MAX	chr17:19437047-19437263	HepG2	liver:	n/a	n/a
39	MAX	chr17:19436769-19437882	A549	lung:	n/a	n/a
40	MAX	chr17:19436954-19437452	SK-N-SH	brain:	n/a	n/a
41	MAZ	chr17:19436718-19437397	HepG2	liver:	n/a	n/a
42	MAZ	chr17:19437634-19437928	HepG2	liver:	n/a	n/a
43	MXI1	chr17:19436721-19438071	HepG2	liver:	n/a	n/a
44	MYBL2	chr17:19437482-19438024	HepG2	liver:	n/a	n/a
45	MYC	chr17:19436478-19436509	MCF-7	breast:	n/a	n/a
46	MYC	chr17:19437149-19437333	HUVEC	blood vessel:	n/a	n/a
47	MYC	chr17:19436540-19436544	MCF-7	breast:	n/a	n/a
48	MYC	chr17:19437030-19437366	MCF-7	breast:	n/a	n/a
49	MYC	chr17:19436411-19436535	MCF-7	breast:	n/a	n/a
50	MYC	chr17:19437142-19437215	MCF-7	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:19436896-19436946	SAEC	small airway:	n/a
2	chr17:19436896-19436946	SAEC	small airway:	n/a
3	chr17:19437691-19437741	SK-N-SH_RA	brain:	n/a
4	chr17:19436770-19436820	HIPEpiC	eye:	n/a
5	chr17:19436896-19436946	GM19239	blood:	n/a
6	chr17:19437889-19437939	Hepatocyte	liver:	n/a
7	chr17:19436770-19436820	H1-hESC	embryonic stem cell:	embryo
8	chr17:19437181-19437231	ovcar-3	ovarian:	n/a
9	chr17:19437181-19437231	T-47D	breast:	n/a
10	chr17:19437157-19437207	Hepatocyte	liver:	n/a
11	chr17:19438253-19438303	PFSK-1	brain:	n/a
12	chr17:19436900-19436950	NHDF-neo	bronchial:	n/a
13	chr17:19437791-19437841	AG10803	skin:	n/a
14	chr17:19438253-19438303	ovcar-3	ovarian:	n/a
15	chr17:19437003-19437053	AG04449	skin:	fetal
16	chr17:19436896-19436946	HL-60	blood:	n/a
17	chr17:19437691-19437741	IMR90	lung:	fetal
18	chr17:19437013-19437063	HCM	heart:	n/a
19	chr17:19436881-19436931	AG09319	gingival:	n/a
20	chr17:19436900-19436950	HPAEpiC	pulmonary alveolar:	n/a
21	chr17:19436896-19436946	AoSMC	blood vessel:	n/a
22	chr17:19437791-19437841	HMEC	breast:	n/a
23	chr17:19437003-19437053	SKMC	muscle:	n/a
24	chr17:19437181-19437231	SK-N-MC	brain:	n/a
25	chr17:19436896-19436946	GM06990	blood:	n/a
26	chr17:19437157-19437207	A549	lung:	n/a
27	chr17:19438253-19438303	LNCaP	prostate:	n/a
28	chr17:19436770-19436820	HRPEpiC	eye:	n/a
29	chr17:19438221-19438271	K562	blood:	n/a
30	chr17:19437013-19437063	AG04449	skin:	fetal
31	chr17:19438221-19438271	MCF-7	breast:	n/a
32	chr17:19436881-19436931	HEEpiC	esophagus:	n/a
33	chr17:19437181-19437231	HCM	heart:	n/a
34	chr17:19436896-19436946	HCF	heart:	n/a
35	chr17:19436770-19436820	HPAEpiC	pulmonary alveolar:	n/a
36	chr17:19437003-19437053	HL-60	blood:	n/a
37	chr17:19437157-19437207	CMK	blood:	n/a
38	chr17:19436770-19436820	Hela-S3	cervix:	n/a
39	chr17:19437157-19437207	AG09309	skin:	n/a
40	chr17:19438253-19438303	GM12891	blood:	n/a
41	chr17:19437157-19437207	PANC-1	pancreas:	n/a
42	chr17:19437013-19437063	SKMC	muscle:	n/a
43	chr17:19436881-19436931	HRPEpiC	eye:	n/a
44	chr17:19437889-19437939	AG09309	skin:	n/a
45	chr17:19437003-19437053	NHBE	bronchial:	n/a
46	chr17:19436881-19436931	GM19239	blood:	n/a
47	chr17:19436900-19436950	HEEpiC	esophagus:	n/a
48	chr17:19436770-19436820	HMEC	breast:	n/a
49	chr17:19437691-19437741	GM06990	blood:	n/a
50	chr17:19437791-19437841	NT2-D1	testis:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr17:19435840..19438479-chr17:19458086..19460035,3	MCF-7	breast:

Variant related genes	Relation type
SLC47A1	TF binding region
SLC47A1	CpG island
ENSG00000142494	chromatin interactions

Extended variants
information (count: 70 )
Associated
traits (count: 154 )

Variant overlapped rSNPs/rCNVs (count:70 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs550752506	chr17:19436468-19436469	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs114707795	chr17:19436474-19436475	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs191381558	chr17:19436481-19436482	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs139192539	chr17:19436485-19436486	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs573304396	chr17:19436530-19436531	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs117182175	chr17:19436600-19436601	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs565793285	chr17:19436644-19436645	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs528161115	chr17:19436651-19436652	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs540424267	chr17:19436699-19436700	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs111369428	chr17:19436706-19436707	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs149968768	chr17:19436740-19436741	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs575462194	chr17:19436743-19436744	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs544403408	chr17:19436756-19436757	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs541894669	chr17:19436778-19436779	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs113977219	chr17:19436806-19436807	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs539981772	chr17:19436864-19436865	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs559701796	chr17:19436925-19436926	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs528872667	chr17:19436964-19436965	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs144892722	chr17:19437005-19437006	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs562049117	chr17:19437013-19437014	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs78077264	chr17:19437044-19437045	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs77379895	chr17:19437050-19437051	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs111620613	chr17:19437081-19437082	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs551144755	chr17:19437094-19437095	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs72466470	chr17:19437135-19437136	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs78903220	chr17:19437141-19437142	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs571004977	chr17:19437178-19437179	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs2252281	chr17:19437187-19437188	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs78572621	chr17:19437200-19437201	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs76654011	chr17:19437205-19437206	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs75517315	chr17:19437208-19437209	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs111427955	chr17:19437209-19437210	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs202150422	chr17:19437223-19437224	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs76164274	chr17:19437226-19437227	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs373989622	chr17:19437237-19437238	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs535874124	chr17:19437241-19437242	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs555657341	chr17:19437280-19437281	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs140752680	chr17:19437333-19437334	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs61733934	chr17:19437339-19437340	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs557911875	chr17:19437358-19437359	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs75393147	chr17:19437401-19437402	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs201320336	chr17:19437425-19437426	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs80090130	chr17:19437456-19437457	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs371755837	chr17:19437490-19437491	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs563282697	chr17:19437518-19437519	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs375767460	chr17:19437535-19437536	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs573255618	chr17:19437549-19437550	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs542226214	chr17:19437578-19437579	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs75088086	chr17:19437598-19437599	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs79121837	chr17:19437635-19437636	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:154)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Autism	22543975	CNVD
Sezary syndrome	18413736	CNVD
Cancer	20164920	CNVD
Bipolar disorder	19114987	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:406 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:19430200-19436600	Weak transcription	Cortex derived primary cultured neurospheres	brain
2	chr17:19435600-19436600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
3	chr17:19436200-19436600	Enhancers	Primary neutrophils fromperipheralblood	blood
4	chr17:19436200-19436600	Bivalent Enhancer	Duodenum Mucosa	Duodenum
5	chr17:19436200-19437200	Flanking Active TSS	Liver	Liver
6	chr17:19436400-19436600	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
7	chr17:19436400-19436600	Flanking Bivalent TSS/Enh	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr17:19436400-19436600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr17:19436400-19436600	Enhancers	Breast Myoepithelial Primary Cells	Breast
10	chr17:19436400-19436600	Bivalent Enhancer	Primary hematopoietic stem cells	blood
11	chr17:19436400-19436600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
12	chr17:19436400-19436600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
13	chr17:19436400-19436600	Enhancers	Adipose Nuclei	Adipose
14	chr17:19436400-19436600	Enhancers	Brain Inferior Temporal Lobe	brain
15	chr17:19436400-19436600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
16	chr17:19436400-19436600	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
17	chr17:19436400-19436600	Active TSS	Stomach Smooth Muscle	stomach
18	chr17:19436400-19436600	Enhancers	HUVEC	blood vessel
19	chr17:19436400-19436800	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
20	chr17:19436400-19436800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
21	chr17:19436400-19436800	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
22	chr17:19436400-19436800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
23	chr17:19436400-19436800	Bivalent Enhancer	Fetal Muscle Leg	muscle
24	chr17:19436400-19436800	Enhancers	Ovary	ovary
25	chr17:19436400-19436800	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
26	chr17:19436400-19436800	Flanking Active TSS	A549	lung
27	chr17:19436400-19437000	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
28	chr17:19436400-19437000	Flanking Bivalent TSS/Enh	HepG2	liver
29	chr17:19436400-19437200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
30	chr17:19436400-19437200	Enhancers	Spleen	Spleen
31	chr17:19436400-19437800	Bivalent/Poised TSS	NHEK	skin
32	chr17:19436400-19438000	Bivalent Enhancer	Fetal Brain Male	brain
33	chr17:19436400-19438200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
34	chr17:19436400-19438400	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
35	chr17:19436400-19438400	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
36	chr17:19436600-19436800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
37	chr17:19436600-19436800	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr17:19436600-19436800	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
39	chr17:19436600-19436800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
40	chr17:19436600-19436800	Flanking Bivalent TSS/Enh	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr17:19436600-19436800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
42	chr17:19436600-19436800	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
43	chr17:19436600-19436800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
44	chr17:19436600-19436800	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
45	chr17:19436600-19436800	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
46	chr17:19436600-19436800	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
47	chr17:19436600-19436800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
48	chr17:19436600-19436800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
49	chr17:19436600-19436800	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
50	chr17:19436600-19436800	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links